Kimryn Rathmell: NCI supports research to improve quality of life for childhood and AYA cancer survivors

Kimryn Rathmell shared a post on X:

“Childhood and AYA cancer survivors often face significant long-term health effects from their disease and its treatment. National Cancer Institute (NCI) supports research to develop and evaluate interventions to improve quality of life for survivors.”    .

Source: Kimryn Rathmell/X

Dr. Kimryn Rathmell is a distinguished leader and researcher in the field of kidney cancer. Specializing in the research and treatment of complex and hereditary kidney cancers. 

She has held leadership positions with organizations such as the American Society of Clinical Oncology and the American Society for Clinical Investigation, she has been elected to esteemed academies including the Association of American Physicians, the American Academy of Arts and Sciences, and the National Academy of Medicine.

Currently serving as the director of the National Cancer Institute, Dr. Rathmell continues to lead research initiatives and advance the understanding and treatment of kidney cancer, ultimately improving the lives of patients worldwide.